Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
Meningitis, Meningococcal
About this trial
This is an interventional prevention trial for Meningitis, Meningococcal focused on measuring Meningococcal Vaccine, Meningococcal Meningitis, Serogroup C, Neisseria Meningitidis
Eligibility Criteria
Inclusion Criteria: Male and female volunteers infants, aged 2 to 6 months Clinically healthy, (i.e. the physician would have no reservations vaccinating with a meningococcal C vaccine outside the scope of a clinical trial) Parent(s)/legal guardian understands the study and has provided written informed consent for his/her infant's study participation Parent(s)/legal guardian and infant will be available for the duration of the study Exclusion Criteria: History of any vaccine-related contraindicating event (e.g. anaphylaxis) Rash or other dermatological condition at the injection site which could interfere with injection site reaction monitoring or lead to a dermatological reaction Subjects who have received or will receive other vaccine(s) ± 30 days before or after the study period Concurrent participation in or previous participation in a clinical trial with an investigational medicinal product Subjects who suffer from a disease (e.g. autoimmune disease) or are undergoing a form of treatment (e.g. systemic corticosteroids, chemotherapeutics) that can be expected to influence immunological functions Subjects who have previously received a vaccination against Hep B or meningococcal C Subjects who have received banked human blood or immunoglobulins within one month of study entry
Sites / Locations
- Freistädter Strasse 290
- Grieskirchner Strasse 17
- Neuschwansteinstrasse 5
- Marktplatz 3
- Hasenheide 66
- Hauptstrasse 9
- Rheinstrasse13
- Solothurner Strasse 2
- Haupstrasse 240
- Löpsinger Strasse 8
- Tuchbergstrasse 2
- Asternweg 11a
- Falkensteiner Strasse 24
- Broner Platz 6